US Broker Ratings

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Through a 52.6% Revenue Growth Amidst a Challenging Valuation Landscape

Oscar Health, Inc. (NYSE: OSCR), a prominent player in the healthcare sector, has been making waves with its innovative approach to health insurance. As a healthcare..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 24.45% Potential Upside in Healthcare Innovation

For investors seeking opportunities within the healthcare sector, Koninklijke Philips N.V. (NYSE: PHG) presents an intriguing proposition. With a market capitalization of $25.66 billion, this Dutch..

Stevanato Group S.p.A. (STVN) Stock Analysis: Unpacking a Potential 37.89% Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), a notable player in the healthcare sector, specifically within the medical instruments and supplies industry, is drawing attention from investors with..

Abbott Laboratories (ABT) Stock Analysis: Tapping Into a 35.73% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector with a market cap of $152.25 billion, presents an intriguing case for investors seeking both stability..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Exploring the 30.95% Potential Upside

Sarepta Therapeutics, Inc. (SRPT), a prominent player in the biotechnology sector, continues to capture investor attention with its strategic focus on RNA-targeted therapeutics and gene therapies..

Tempus AI, Inc. (TEM) Stock Analysis: A Balanced Look at Its 45% Potential Upside

Tempus AI, Inc. (NASDAQ: TEM), a prominent player in the healthcare technology sector, presents a compelling opportunity for investors seeking growth in the ever-evolving health information..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a Promising 1.5% Potential Upside in the Healthcare Sector

Elevance Health, Inc. (NYSE: ELV), a major player in the U.S. healthcare plans industry, is attracting attention with its substantial market cap of $85.71 billion and..

Hologic, Inc. (HOLX) Stock Analysis: Navigating Steady Growth in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX) stands as a key player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of..

Krystal Biotech (KRYS) Investor Outlook: Robust Growth Prospects with 8.32% Potential Upside

Krystal Biotech, Inc. (NASDAQ: KRYS) is drawing significant attention in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $8.83 billion, this..

Takeda Pharmaceutical (TAK) Stock Analysis: Exploring a Promising 25.97% Upside Potential

Takeda Pharmaceutical Company Limited (NYSE: TAK), a titan in the healthcare sector, stands as a compelling investment opportunity for those eyeing the drug manufacturing industry. With..

Integer Holdings Corporation (ITGR) Stock Analysis: Navigating Growth Amidst Valuation Challenges

Integer Holdings Corporation (NYSE: ITGR) is a notable player in the healthcare sector, specializing in medical devices. With its headquarters in Plano, Texas, the company has..

HCA Healthcare, Inc. (HCA) Stock Analysis: A Potential 29.66% Upside Amid Strong Analyst Confidence

HCA Healthcare, Inc. (NYSE: HCA), a titan in the medical care facilities industry, commands attention with a market capitalization of $87.42 billion. Based in Nashville, Tennessee,..

Atrium Therapeutics, Inc. (RNA) Stock Analysis: Exploring a 90.99% Potential Upside in RNA Therapeutics

Atrium Therapeutics, Inc. (NASDAQ: RNA) is capturing investor attention with a remarkable potential upside of 90.99%, according to recent analyst ratings. This San Diego-based biopharmaceutical company..

Biogen Inc. (BIIB) Stock Analysis: Navigating a Potential 13% Upside Amidst Robust Drug Pipeline

Biogen Inc. (NASDAQ: BIIB), a stalwart in the healthcare sector, stands as a significant player within the general drug manufacturing industry. With a current market capitalization..

Quest Diagnostics (DGX) Stock Analysis: Exploring a 14.46% Potential Upside in the Diagnostics Sector

Quest Diagnostics Incorporated (NYSE: DGX), a key player in the Healthcare sector, specifically within the Diagnostics & Research industry, is currently garnering significant attention from investors...

AptarGroup, Inc. (ATR) Stock Analysis: A 40% Upside Potential in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) stands out as a compelling investment opportunity in the healthcare sector, particularly for investors eyeing growth potential. As a key player in..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling an 88.61% Potential Upside in Biotechnology

Legend Biotech Corporation (NASDAQ: LEGN), a promising player in the biotechnology sector, has captured investor attention with its innovative approach to combating cancer through novel cell..

Telix Pharmaceuticals Limited (TLX): Investor Outlook on a Biotech Powerhouse with 123.80% Potential Upside

Telix Pharmaceuticals Limited (ASX: TLX), an Australian-based biopharmaceutical company, is drawing significant attention from investors, especially with a projected 123.80% potential upside. As a key player..

Jazz Pharmaceuticals plc (JAZZ) Stock Analysis: Strong Buy Ratings and Promising Pipeline Propel Growth Potential

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, is swiftly capturing investor attention with its robust pipeline and consistent financial performance. Headquartered..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 39% Upside Potential Amidst Strong Analyst Ratings

Prestige Consumer Healthcare Inc. (PBH) finds itself uniquely positioned within the healthcare sector, particularly in the niche of over-the-counter (OTC) drug manufacturing. A staple in households..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds